A 72-year-old female with advanced rectal cancer presented with obstructive jaundice 6 months after undergoing left hepatic lobectomy for liver metastases. Computed tomography revealed a dilated right intrahepatic bile duct, and a new liver metastasis appeared in her right hepatic lobe \[[Figure 1a](#F1){ref-type="fig"}\]. Endoscopic retrograde cholangiopancreatography (ERCP) revealed severe stricture at the hepatic hilum; however, insertion of an ERCP catheter into the right anterior intrahepatic duct was unsuccessful \[[Figure 1b](#F1){ref-type="fig"}\]. Subsequently, endoscopic ultrasonography-guided right hepatic bile duct drainage (EUS-RBD) was attempted. The right anterior intrahepatic duct could be well-visualized with an echoendoscope from the duodenal bulb and was punctured with a 19-gauge aspiration needle \[[Figure 2a](#F2){ref-type="fig"}\]. A 0.025-inch angle-tip guidewire (VisiGlide 2; Olympus Medical Systems, Tokyo, Japan) was inserted into the biliary system \[[Figure 2b](#F2){ref-type="fig"}\], and following dilation of the fistula track by a 7-Fr biliary bougie dilator (Soehendra Biliary Dilation Catheter, Cook Medical, Winston-Salem, North Carolina, USA), a covered self-expandable metal stent (10 mm × 100 mm, Niti-S Biliary Covered Stent; Taewoong Medical, Seoul, South Korea) was successfully deployed through the duodenal bulb \[[Figure 2c](#F2){ref-type="fig"} and [Video 1](#SD1){ref-type="supplementary-material"}\]. The total procedure time was 42 min. The postoperative period was uneventful, and both jaundice and never mentioned before resolved in a week. Chemotherapy was resumed for advanced rectal cancer immediately after discharge. The patient died 767 days after EUS-RBD because of the progression of her underlying disease; however, she remained free of jaundice until death.

![(a) Computed tomography image showing a dilated right intrahepatic bile duct and liver metastasis in the right hepatic lobe. (b) Cholangiography image obtained by endoscopic retrograde cholangiopancreatography showing a severe stricture at the hepatic hilum. Repeated attempts to insert an endoscopic retrograde cholangiopancreatography catheter into the right anterior intrahepatic duct failed](EUS-6-412-g001){#F1}

![(a) The right anterior intrahepatic duct was punctured using a 19-gauge aspiration needle under endosonographic guidance. (b) After the injection of contrast agent, a 0.025-inch guidewire was inserted into the biliary system. (c) A covered metal stent (10 mm wide and 100 mm long) was successfully deployed into the right hepatic bile duct via the duodenal bulb](EUS-6-412-g002){#F2}

EUS-guided biliary drainage is a recently developed alternative technique in patients with biliary obstruction for failed ERCP.\[[@ref1][@ref2]\] Various techniques have been described; however, limited data are available regarding EUS-RBD\[[@ref3][@ref4][@ref5]\] and long-term follow-up data are lacking. This is the first case which attained long-term stent patency in EUS-RBD after left hepatic lobectomy.

The use of the Spyglass System (Boston Scientific, Natick, Massachusetts, USA) to facilitate selective placement of a guidewire in the context of difficult biliary strictures has been reported.\[[@ref6]\] However, even if a guidewire had been successfully inserted across this stricture, the configuration and site of the stricture would have made placement of a self-expandable metal stent difficult, and a plastic stent would have to be used. Plastic stents tend to occlude within a few months, and the patient would have had to undergo repeat ERCP procedures for palliative drainage. In contrast, EUS-RBD using a self-expandable metal stent allowed long lasting effective drainage.

In conclusion, EUS-RBD could be an effective palliative option for right intrahepatic bile duct drainage, which is expected to maintain the patient\'s quality of life and achieve long-term stent patency and survival.
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